Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Mov Disord. 2014 May 16;29(8):1069–1074. doi: 10.1002/mds.25912

Table 2.

Clinical information on PD subgroups according to history of smoking

History of Smoking Yes No P value
Number (F/M) 22 (8/14) 54 (20/34) 1.00
Age (y; mean±SD) 65.8±7.5 61.0±8.5 0.02
Duration of Illness (y; mean±SD) 4.4±5.2 5.2±5.7 0.11
Age at Diagnosis (y; mean±SD) 61.4±7.8 55.9± 7.6 0.02
LEDD (mg; mean±SD) 520±433 559± 435 0.36
UPDRS-III (mean±SD) 24.5±13.8 22.3± 14.8 0.84
MMSE (mean±SD) 29.1±1.1 29.2±1.1 0.74
MAOI (%, rasagiline/selegiline) 31.8% (9:7) 31.5% (17:22) 1.00

Abbreviations: LEDD: Levodopa equivalent daily dose; MAOI: Monoamine oxidase B inhibitors; MMSE: Mini Mental Status Examination; UPDRS-III: Unified Parkinson’s Disease Rating Scale section III motor scores; UPSIT: University of Pennsylvania Smell Identification Test